VIGL — Vigil Neuroscience Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Vigil Neuroscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	24.2	91.4	187	118	97.8
Prepaid Expenses
Total Current Assets	25.3	97.5	198	122	101
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	1.27	1.4	17.9	16.1
Other Long Term Assets
Total Assets	25.3	102	200	141	118
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2	9.88	11.3	11.7	34.1
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.54	9.95	11.3	24.6	46.1
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	18.8	92.5	189	116	71.6
Total Liabilities & Shareholders' Equity	25.3	102	200	141	118
Total Common Shares Outstanding